32. Prevention: Clinical 1161-111

1161-111 - EFFECTS OF SEMAGLUTIDE VERSUS COMPARATORS ON CARDIOVASCULAR EVENTS ACROSS A CONTINUUM OF BASELINE CARDIOVASCULAR RISK: COMBINED ANALYSIS OF THE SUSTAIN AND PIONEER TRIALS

Session
1161 - Prevention: Clinical 2
Speakers
Pathway
32. Prevention: Clinical
Presentation Number
1161-111
Presentation Rating
 |